{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:48:42Z","timestamp":1790952522129,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018515","name":"Hamburger Krebsgesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018515","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013651","name":"Deutsche Wirbels\u00e4ulenstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013651","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.imlet.2026.107135","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T23:42:30Z","timestamp":1767397350000},"page":"107135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Enrichment of CD103+ CD4+ T cells in bone metastases compared to non-malignant controls"],"prefix":"10.1016","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2477-2664","authenticated-orcid":false,"given":"Elias","family":"Brauneck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Kylies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Assemissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Kruppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Kruppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagana","family":"Wahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Brauneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9353-667X","authenticated-orcid":false,"given":"Lennart","family":"Viezens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Wellbrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3966-8537","authenticated-orcid":false,"given":"Leon-Gordian","family":"Leonhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imlet.2026.107135_bib0001","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12885-017-3922-0","article-title":"Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States","volume":"18","author":"Hernandez","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.imlet.2026.107135_bib0002","first-page":"321","article-title":"Bone metastases: an overview","volume":"11","author":"Macedo","year":"2017","journal-title":"Oncol. Rev"},{"key":"10.1016\/j.imlet.2026.107135_bib0003","article-title":"Impact of bone metastasis on prognosis in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"15","author":"Zhu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.imlet.2026.107135_bib0004","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/0-387-26283-0_5","article-title":"The role of immune cells in the tumor microenvironment","volume":"130","author":"Whiteside","year":"2006","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.imlet.2026.107135_bib0005","article-title":"The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy","volume":"13","author":"Lu","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.imlet.2026.107135_bib0006","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nri.2015.10","article-title":"The multifaceted role of CD4(+) T cells in CD8(+) T cell memory","volume":"16","author":"Laidlaw","year":"2016","journal-title":"Nat. Rev. Immunol"},{"issue":"24","key":"10.1016\/j.imlet.2026.107135_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246211","article-title":"Integrin \u03b1(E)(CD103)\u03b2(7) in epithelial cancer","volume":"13","author":"Hoffmann","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.imlet.2026.107135_bib0008","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3389\/fimmu.2018.01904","article-title":"The emerging role of CD8(+) tissue resident memory T (T(RM)) cells in antitumor immunity: a unique functional contribution of the CD103 integrin","volume":"9","author":"Corgnac","year":"2018","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2026.107135_bib0009","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1038\/s41467-018-05072-0","article-title":"Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors","volume":"9","author":"Duhen","year":"2018","journal-title":"Nat. Commun"},{"issue":"1","key":"10.1016\/j.imlet.2026.107135_bib0010","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1844402","article-title":"Intratumoral CD103(+)CD4(+) T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients","volume":"9","author":"Gu","year":"2020","journal-title":"Oncoimmunology"},{"issue":"12","key":"10.1016\/j.imlet.2026.107135_bib0011","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat. Rev. Clin. Oncol"},{"issue":"5","key":"10.1016\/j.imlet.2026.107135_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental relationships of four exhausted CD8(+) T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms","volume":"52","author":"Beltra","year":"2020","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.imlet.2026.107135_bib0013","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining 'T cell exhaustion","volume":"19","author":"Blank","year":"2019","journal-title":"Nat. Rev. Immunol"},{"issue":"1","key":"10.1016\/j.imlet.2026.107135_bib0014","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1038\/s41467-023-40755-3","article-title":"TIGIT can inhibit T cell activation via ligation-induced nanoclusters, independent of CD226 co-stimulation","volume":"14","author":"Worboys","year":"2023","journal-title":"Nat. Commun"},{"issue":"2","key":"10.1016\/j.imlet.2026.107135_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000957","article-title":"TIGIT in cancer immunotherapy","volume":"8","author":"Chauvin","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"22","key":"10.1016\/j.imlet.2026.107135_bib0016","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163620","article-title":"Blockade of the immunosuppressive KIR2DL5\/PVR pathway elicits potent human NK cell-mediated antitumor immunity","volume":"132","author":"Ren","year":"2022","journal-title":"J. Clin. Invest"},{"issue":"12","key":"10.1016\/j.imlet.2026.107135_bib0017","article-title":"Nectins and nectin-like molecules in colorectal cancer: role in diagnostics, prognostic values, and emerging treatment options: a literature review","volume":"12","author":"Kobecki","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"10","key":"10.1016\/j.imlet.2026.107135_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102712","article-title":"TIGIT expression on activated NK cells correlates with greater anti-tumor activity but promotes functional decline upon lung cancer exposure: implications for adoptive cell therapy and TIGIT-targeted therapies","volume":"15","author":"Hasan","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.imlet.2026.107135_bib0019","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.3324\/haematol.2020.258574","article-title":"PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemia","volume":"106","author":"Li","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.imlet.2026.107135_bib0020","doi-asserted-by":"crossref","first-page":"10453","DOI":"10.2147\/OTT.S272553","article-title":"High expression of CD39 is associated with poor prognosis and immune infiltrates in clear cell renal cell carcinoma","volume":"13","author":"Wu","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/j.imlet.2026.107135_bib0021","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1930391","article-title":"Increased frequency of TIGIT(+)CD73-CD8(+) T cells with a TOX(+) TCF-1low profile in patients with newly diagnosed and relapsed AML","volume":"10","author":"Brauneck","year":"2021","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.imlet.2026.107135_bib0022","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2346359","article-title":"Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction","volume":"13","author":"Witt","year":"2024","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.imlet.2026.107135_bib0023","article-title":"Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction","volume":"13","author":"Marius","year":"2024","journal-title":"Oncoimmunology"},{"issue":"46","key":"10.1016\/j.imlet.2026.107135_bib0024","doi-asserted-by":"crossref","first-page":"75130","DOI":"10.18632\/oncotarget.12077","article-title":"CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse tcr\u03b1\u03b2+ CD8\u03b1\u03b2+ T cells that can be targeted for cancer immunotherapy","volume":"7","author":"Komdeur","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.imlet.2026.107135_bib0025","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1002\/ijc.25902","article-title":"CD103 is a hallmark of tumor-infiltrating regulatory T cells","volume":"129","author":"Anz","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.imlet.2026.107135_bib0026","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s43018-023-00547-6","article-title":"CD103(+) regulatory T cells underlie resistance to radio-immunotherapy and impair CD8(+) T cell activation in glioblastoma","volume":"4","author":"van Hooren","year":"2023","journal-title":"Nat. Cancer"},{"issue":"10","key":"10.1016\/j.imlet.2026.107135_bib0027","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1158\/2326-6066.CIR-20-0270","article-title":"CD39 Identifies the CD4(+) tumor-specific T-cell population in Human cancer","volume":"8","author":"Kortekaas","year":"2020","journal-title":"Cancer Immunol. Res"},{"issue":"5","key":"10.1016\/j.imlet.2026.107135_bib0028","article-title":"TGF-beta: many paths to CD103(+) CD8","volume":"10","author":"Qiu","year":"2021","journal-title":"T Cell Residency. Cells."},{"issue":"12","key":"10.1016\/j.imlet.2026.107135_bib0029","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/ni.2744","article-title":"The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin","volume":"14","author":"Mackay","year":"2013","journal-title":"Nat. Immunol"},{"issue":"2","key":"10.1016\/j.imlet.2026.107135_bib0030","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1158\/1078-0432.CCR-13-1877","article-title":"Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer","volume":"20","author":"Webb","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.imlet.2026.107135_bib0031","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00262-022-03240-2","article-title":"The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer","volume":"72","author":"Nose","year":"2023","journal-title":"Cancer Immunol. Immunother"},{"issue":"9","key":"10.1016\/j.imlet.2026.107135_bib0032","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1338230","article-title":"CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer","volume":"6","author":"Komdeur","year":"2017","journal-title":"Oncoimmunology"},{"issue":"13","key":"10.1016\/j.imlet.2026.107135_bib0033","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1158\/1078-0432.CCR-17-2257","article-title":"CD103(+) Tumor-resident CD8(+) T cells are associated with improved survival in immunotherapy-na\u00efve melanoma patients and expand significantly during Anti-PD-1 treatment","volume":"24","author":"Edwards","year":"2018","journal-title":"Clin. Cancer Res"},{"issue":"21","key":"10.1016\/j.imlet.2026.107135_bib0034","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1200\/JCO.2011.37.8539","article-title":"Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma","volume":"30","author":"Azimi","year":"2012","journal-title":"J. Clin. Oncol"},{"issue":"5795","key":"10.1016\/j.imlet.2026.107135_bib0035","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.imlet.2026.107135_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113770","article-title":"Transcriptional activity and stability of CD39+CD103+CD8+ T cells in Human high-grade endometrial cancer","volume":"21","author":"Workel","year":"2020","journal-title":"Int. J. Mol. Sci"},{"issue":"1","key":"10.1016\/j.imlet.2026.107135_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001807","article-title":"CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma","volume":"9","author":"Lai","year":"2021","journal-title":"J. Immunother Cancer"},{"issue":"6","key":"10.1016\/j.imlet.2026.107135_bib0038","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41416-023-02558-7","article-title":"Soluble lymphocyte activation gene-3 (sLAG3) and CD4\/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies","volume":"130","author":"Gorgulho","year":"2024","journal-title":"Br J. Cancer"},{"issue":"20","key":"10.1016\/j.imlet.2026.107135_bib0039","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1158\/1078-0432.CCR-09-1143","article-title":"Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer","volume":"15","author":"Mandapathil","year":"2009","journal-title":"Clin. Cancer Res"},{"issue":"6","key":"10.1016\/j.imlet.2026.107135_bib0040","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1593809","article-title":"The role of NK cells and CD39 in the immunological control of tumor metastases","volume":"8","author":"Zhang","year":"2019","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.imlet.2026.107135_bib0041","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12967-022-03480-x","article-title":"Blocking TIGIT\/CD155 signalling reverses CD8(+) T cell exhaustion and enhances the antitumor activity in cervical cancer","volume":"20","author":"Liu","year":"2022","journal-title":"J. Transl. Med"},{"issue":"1","key":"10.1016\/j.imlet.2026.107135_bib0042","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12943-023-01800-3","article-title":"Co-inhibition of TIGIT and PD-1\/PD-L1 in cancer immunotherapy: mechanisms and clinical trials","volume":"22","author":"Chu","year":"2023","journal-title":"Mol. Cancer"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247826000088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247826000088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:55:08Z","timestamp":1773982508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247826000088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":42,"alternative-id":["S0165247826000088"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107135","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enrichment of CD103+ CD4+ T cells in bone metastases compared to non-malignant controls","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}],"article-number":"107135"}}